Aulos Bioscience, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://aulosbio.com
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-03-04
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Aulos Bioscience, Inc.
- Target Recruit Count
- 159
- Registration Number
- NCT05267626
- Locations
- 🇺🇸
University of Utah - Huntsman Cancer Institute, Salt Lake City, Utah, United States
🇦🇺Southern Oncology Clinical Research Unit, Bedford Park, South Australia, Australia
🇺🇸START Midwest, Grand Rapids, Michigan, United States
© Copyright 2024. All Rights Reserved by MedPath